Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...

U.S. health agency leadership and policymakers seem intent on undermining trust in mRNA, the technology that saved millions of lives during the COVID pandemic and has shown promise in addressing a ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...

The fears over mRNA-vaccine grant cancellations come after NIH staff members were instructed to compile a list of grants for ...

Rep. Marjorie Taylor Greene calls for yanking FDA approval of COVID-19 vaccines, says that "COVID-19 vaccines are causing ...

The National Institutes of Health under President Donald Trump canceled more than 40 grants related to vaccine hesitancy, according to NPR. Officials with the NIH also urged scientists to remove ...

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential ...